JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-8.91 Cr | ₹-0.46 Cr | ₹-18 Cr | ₹-6.83 Cr | ₹-1.82 Cr |
What is the latest Cash Flow from Financing Activities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-8.91 Cr |
Mar2023 | ₹-0.46 Cr |
Mar2022 | ₹-18 Cr |
Mar2021 | ₹-6.83 Cr |
Mar2020 | ₹-1.82 Cr |
How is Cash Flow from Financing Activities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.91 Cr | Negative | |
Mar2023 | ₹-0.46 Cr | Negative | |
Mar2022 | ₹-18 Cr | Negative | |
Mar2021 | ₹-6.83 Cr | Negative | |
Mar2020 | ₹-1.82 Cr | - |
Compare Cash Flow from Financing Activities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,388.1 Cr | -3.3% | -21.3% | 72.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | -3.3% |
-21.3% |
72.6% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses